What is the typical presentation of a young patient of African or Afro‑Caribbean descent with sickle‑cell hemoglobin C disease (HbSC)?

Typical Presentation of Sickle Cell-Hemoglobin C Disease (HbSC)

Overview

Patients with HbSC disease typically present with a milder phenotype than HbSS disease, characterized by higher baseline hemoglobin levels (often near-normal), less frequent painful crises, and later onset of symptoms—yet they remain at significant risk for serious complications including proliferative retinopathy, splenic sequestration (even in adolescence and adulthood), avascular necrosis, and acute chest syndrome. 1

Demographics and Epidemiology

• HbSC disease is the second most common sickle cell disease genotype after HbSS, accounting for approximately 40% of sickle cell disease cases in some West African populations. 2
• Patients are predominantly of African or Afro-Caribbean descent, though the condition also occurs in individuals from the Middle East, India, and the Mediterranean region. 3
• Many patients remain undiagnosed until adolescence or adulthood because symptoms are less severe and may be absent during childhood, leading to presentation only when a significant complication occurs. 4, 5

Hematologic Profile

• Baseline hemoglobin levels are significantly higher than HbSS disease, typically ranging from 10-12 g/dL compared to 6-9 g/dL in HbSS. 1, 6
• Hemoglobin composition shows approximately 50% HbS and 50% HbC with no normal HbA present. 7
• Chronic hemolytic anemia is present but less severe than in HbSS disease, with lower reticulocyte counts and less prominent jaundice. 6
• Blood smears show target cells prominently in addition to sickled cells, reflecting the presence of HbC. 6

Clinical Manifestations

Acute Complications

• Vaso-occlusive pain crises occur but are less frequent than in HbSS disease, though they remain the most common cause of hospitalization when they do occur. 3, 6
• Acute chest syndrome can develop and may be life-threatening, requiring aggressive treatment with oxygen, antibiotics, and often transfusion. 1
• Splenic sequestration is particularly notable in HbSC because it can occur at any age, including adolescence and adulthood, unlike HbSS where the spleen typically auto-infarcts by age 5. 1
  • Presents with rapidly enlarging spleen, acute anemia (hemoglobin drop >2 g/dL below baseline), and potential hypovolemic shock. 3
  • Requires urgent recognition and careful transfusion to avoid overtransfusion when sequestered cells are released. 1

Chronic Complications

• Proliferative retinopathy is especially common in HbSC disease, more so than in HbSS, and can lead to retinal detachment and vision loss. 3, 1
  • Annual dilated fundoscopic examination is essential starting from age 10. 1
• Avascular necrosis of the hips and shoulders occurs commonly, causing chronic pain and disability. 3, 1
• Cholelithiasis (gallstones) develops frequently due to chronic hemolysis, presenting with right upper quadrant pain, vomiting, and worsening jaundice. 3, 4
  • Can progress to choledocholithiasis and acute cholangitis, which may be life-threatening. 4
• Renal dysfunction may develop, though less commonly than in HbSS disease. 1
• Pulmonary hypertension can occur, particularly in adults. 3

Cardiovascular Findings

• Blood pressure deviates less from population norms compared to HbSS disease, where baseline blood pressures are typically lower. 1
• Relative hypertension (systolic 120-139 mmHg or diastolic 70-89 mmHg) carries increased risk for pulmonary hypertension and renal dysfunction. 1

Laboratory Characteristics

• Less prominent inflammatory markers compared to HbSS disease, with lower white blood cell counts and less elevation of acute phase reactants. 6
• Lipid abnormalities may be more pronounced in HbSC than in HbSS disease. 6
• Hemolytic markers (LDH, indirect bilirubin, low haptoglobin) are present but less severe than in HbSS disease. 6

Common Pitfalls in Recognition

• The milder phenotype leads to delayed or missed diagnosis, with some patients presenting for the first time in adulthood with serious complications like pulmonary embolism, cholangitis, or hemolytic crisis. 4, 5
• Clinicians may underestimate disease severity because of higher hemoglobin levels and fewer symptoms, leading to inadequate surveillance and preventive care. 2
• Splenic sequestration in adolescents and adults may not be considered because providers expect the spleen to be auto-infarcted as in HbSS disease. 1
• Approximately 10% of adults with HbSC meet criteria for severe disease (≥3 pain crises per year, acute chest syndrome, or severe symptomatic anemia), yet less than 1% receive hydroxyurea therapy. 2

Essential Management Considerations

• Comprehensive multidisciplinary care is required despite the milder phenotype, including comanagement between primary care and hematology specialists. 1
• Penicillin prophylaxis and enhanced vaccination schedules (pneumococcal, meningococcal, influenza) are recommended based on specific diagnosis. 1
• Any fever ≥38.5°C requires urgent evaluation due to functional asplenia, though the risk is lower than in HbSS disease. 1
• For transfusions, use extended red blood cell antigen matching (C, E, K antigens) to prevent alloimmunization. 1
• Avoid iron supplementation unless iron deficiency is biochemically proven, as repeated transfusions carry risk of iron overload. 3